Causes of Death Following PCI Versus CABG in Complex CAD 5-Year Follow-Up of SYNTAX

Journal of the American College of Cardiology

Volumn 67, Issue 1, 2016, Pages 42-55

  Milojevic, Milan ^a   Head, Stuart J ^a   Parasca, Catalina A ^a   Serruys, Patrick W ^a   Mohr, Friedrich W ^b   Morice, Marie Claude ^c   Mack, Michael J ^d   Ståhle, Elisabeth ^e   Feldman, Ted E ^f   Dawkins, Keith D ^g   Colombo, Antonio ^h   Kappetein, A Pieter ^a   Holmes, David R ⁱ  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c INSTITUT CARDIOVASCULAIRE PARIS SUD   (France)

^d THE HEART HOSPITAL BAYLOR PLANO   (United States)

^e UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^f EVANSTON HOSPITAL   (United States)

^g BOSTON SCIENTIFIC CORPORATION   (United States)

^h EMO GVM CENTRO CUORE COLUMBUS   (Italy)

ⁱ MAYO CLINIC ROCHESTER   (United States)

Author keywords

cause of death; coronary artery bypass grafting; heart failure; Key Words cardiac death; myocardial infarction; percutaneous coronary intervention; stroke; sudden death; SYNTAX

Indexed keywords

ADULT; AGED; CAUSE OF DEATH; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HEART DEATH; HEART FAILURE; HEART INFARCTION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTICENTER STUDY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; SUDDEN CARDIAC DEATH; TREATMENT OUTCOME; CLINICAL TRIAL; COMPARATIVE STUDY; CORONARY DISEASE; DRUG ELUTING STENT; MORTALITY; SURVIVAL RATE; TIME FACTOR;

AGED; CAUSE OF DEATH; CORONARY ARTERY BYPASS; CORONARY DISEASE; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84952908312     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2015.10.043     Document Type: Article

References (42)

1. S. Windecker, P. Kolh, F. Alfonso, and et al. 2014 ESC/EACTS guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) Eur Heart J 35 2014 2541 2619
2. S. Deb, H.C. Wijeysundera, D.T. Ko, H. Tsubota, S. Hill, and S.E. Fremes Coronary artery bypass graft surgery vs percutaneous interventions in coronary revascularization: a systematic review JAMA 310 2013 2086 2095
3. D.R. Holmes Jr.; J.W. Moses, J. Schofer, M.C. Morice, E. Schampaert, and M.B. Leon Cause of death with bare metal and sirolimus-eluting stents Eur Heart J 27 2006 2815 2822
4. J. Herlitz, G. Brandrup-Wognsen, K. Caidahl, and et al. Cause of death during 13 years after coronary artery bypass grafting with emphasis on cardiac death Scand Cardiovasc J 38 2004 283 286
5. D.R. Holmes Jr.; K.B. Davis, M.B. Mock, and et al. The effect of medical and surgical treatment on subsequent sudden cardiac death in patients with coronary artery disease: a report from the Coronary Artery Surgery Study Circulation 73 1986 1254 1263
6. D.R. Holmes Jr.; L.J. Kim, M.M. Brooks, and et al. The effect of coronary artery bypass grafting on specific causes of long-term mortality in the Bypass Angioplasty Revascularization Investigation J Thorac Cardiovasc Surg 134 2007 38 46 46 e1
7. S.J. Head, S. Kaul, M.J. Mack, and et al. The rationale for heart team decision-making for patients with stable, complex coronary artery disease Eur Heart J 34 2013 2510 2518
8. P.W. Serruys, M.C. Morice, A.P. Kappetein, and et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease N Engl J Med 360 2009 961 972
9. A.P. Kappetein, T.E. Feldman, M.J. Mack, and et al. Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial Eur Heart J 32 2011 2125 2134
10. S.J. Head, D.R. Holmes Jr.; M.J. Mack, and et al. Risk profile and 3-year outcomes from the SYNTAX percutaneous coronary intervention and coronary artery bypass grafting nested registries J Am Coll Cardiol Intv 5 2012 618 625
11. S.B. King 3rd, S.C. Smith Jr.; J.W. Hirshfeld Jr.; and et al. 2007 focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: 2007 Writing Group to Review New Evidence and Update the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention, Writing on Behalf of the 2005 Writing Committee J Am Coll Cardiol 51 2008 172 209
12. K.A. Eagle, R.A. Guyton, R. Davidoff, and et al. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery) J Am Coll Cardiol 44 2004 1146 1154
13. D.E. Cutlip, S. Windecker, R. Mehran, and et al. Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351
14. P. Grambsch, and T. Therneau Proportional hazards tests and diagnostics based on weighted residuals Biometrika 81 1994 515 526
15. J. Daemen, E. Boersma, M. Flather, and et al. Long-term safety and efficacy of percutaneous coronary intervention with stenting and coronary artery bypass surgery for multivessel coronary artery disease: a meta-analysis with 5-year patient-level data from the ARTS, ERACI-II, MASS-II, and SoS trials Circulation 118 2008 1146 1154
16. M.A. Hlatky, D.B. Boothroyd, D.M. Bravata, and et al. Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials Lancet 373 2009 1190 1197
17. D.B. Spoon, P.J. Psaltis, M. Singh, and et al. Trends in cause of death after percutaneous coronary intervention Circulation 129 2014 1286 1294
18. P. Carson, J. Wertheimer, A. Miller, and et al. The STICH trial (Surgical Treatment for Ischemic Heart Failure): mode-of-death results J Am Coll Cardiol HF 1 2013 400 408
19. K. Nishiyama, S. Shizuta, T. Doi, and et al. Sudden cardiac death after PCI and CABG in the bare-metal stent era: incidence, prevalence, and predictors Int J Cardiol 144 2010 263 266
20. B.R. Chaitman, R.M. Hardison, D. Adler, and et al. The Bypass Angioplasty Revascularization Investigation 2 Diabetes randomized trial of different treatment strategies in type 2 diabetes mellitus with stable ischemic heart disease: impact of treatment strategy on cardiac mortality and myocardial infarction Circulation 120 2009 2529 2540
21. G.G. Stefanini, and D.R. Holmes Jr. Drug-eluting coronary-artery stents N Engl J Med 368 2013 254 265
22. P.A. Tonino, B. De Bruyne, N.H. Pijls, and et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention N Engl J Med 360 2009 213 224
23. L. Mauri, D.J. Kereiakes, R.W. Yeh, and et al. Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents N Engl J Med 371 2014 2155 2166
24. G. Montalescot, D. Brieger, A.J. Dalby, and et al. Duration of dual antiplatelet therapy after coronary stenting: a review of the evidence J Am Coll Cardiol 66 2015 832 847
25. D.W. Park, Y.H. Kim, S.C. Yun, and et al. Long-term outcomes after stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: 10-year results of bare-metal stents and 5-year results of drug-eluting stents from the ASAN-MAIN (ASAN Medical Center-Left MAIN Revascularization) Registry J Am Coll Cardiol 56 2010 1366 1375
26. V. Farooq, P.W. Serruys, C.V. Bourantas, and et al. Quantification of incomplete revascularization and its association with five-year mortality in the synergy between percutaneous coronary intervention with taxus and cardiac surgery (SYNTAX) trial validation of the residual SYNTAX score Circulation 128 2013 141 151
27. F.W. Mohr, M.C. Morice, A.P. Kappetein, and et al. Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial Lancet 381 2013 629 638
28. M.E. Farkouh, M. Domanski, L.A. Sleeper, and et al. Strategies for multivessel revascularization in patients with diabetes N Engl J Med 367 2012 2375 2384
29. S.J. Head, M.J. Mack, D.R. Holmes Jr.; and et al. Incidence, predictors and outcomes of incomplete revascularization after percutaneous coronary intervention and coronary artery bypass grafting: a subgroup analysis of 3-year SYNTAX data Eur J Cardiothorac Surg 41 2012 535 541
30. V. Farooq, P.W. Serruys, H.M. Garcia-Garcia, and et al. The negative impact of incomplete angiographic revascularization on clinical outcomes and its association with total occlusions: the SYNTAX (Synergy Between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery) trial J Am Coll Cardiol 61 2013 282 294
31. S. Garg, G. Sarno, C. Girasis, and et al. A patient-level pooled analysis assessing the impact of the SYNTAX (synergy between percutaneous coronary intervention with taxus and cardiac surgery) score on 1-year clinical outcomes in 6,508 patients enrolled in contemporary coronary stent trials J Am Coll Cardiol Intv 4 2011 645 653
32. A.P. Kappetein, S.J. Head, M.C. Morice, and et al. Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial Eur J Cardiothorac Surg 43 2013 1006 1013
33. M.M. Brooks, R.H. Jones, R.G. Bach, et al. for the BARI Investigators Predictors of mortality and mortality from cardiac causes in the Bypass Angioplasty Revascularization Investigation (BARI) randomized trial and registry Circulation 101 2000 2682 2689
34. G.D. Dangas, M.E. Farkouh, L.A. Sleeper, and et al. Long-term outcome of PCI versus CABG in insulin and non-insulin-treated diabetic patients: results from the FREEDOM trial J Am Coll Cardiol 64 2014 1189 1197
35. S.J. Head, P.M. Davierwala, P.W. Serruys, and et al. Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trial Eur Heart J 35 2014 2821 2830
36. G. Athappan, E. Patvardhan, M.E. Tuzcu, S. Ellis, P. Whitlow, and S.R. Kapadia Left main coronary artery stenosis: a meta-analysis of drug-eluting stents versus coronary artery bypass grafting J Am Coll Cardiol Intv 6 2013 1219 1230
37. D.M. Shahian, S.M. O'Brien, S. Sheng, and et al. Predictors of long-term survival after coronary artery bypass grafting surgery: results from the Society of Thoracic Surgeons Adult Cardiac Surgery Database (the ASCERT study) Circulation 125 2012 1491 1500
38. C. Wu, F.T. Camacho, A.S. Wechsler, and et al. Risk score for predicting long-term mortality after coronary artery bypass graft surgery Circulation 125 2012 2423 2430
39. P. Amarenco, P.C. Lavallee, J. Labreuche, and et al. Coronary artery disease and risk of major vascular events after cerebral infarction Stroke 44 2013 1505 1511
40. J. Iqbal, Y.J. Zhang, D.R. Holmes, and et al. Optimal medical therapy improves clinical outcomes in patients undergoing revascularization with percutaneous coronary intervention or coronary artery bypass grafting: insights from the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial at the 5-year follow-up Circulation 131 2015 1269 1277
41. V. Bittner, M. Bertolet, R. Barraza Felix, and et al. Comprehensive cardiovascular risk factor control improves survival: the BARI 2D trial J Am Coll Cardiol 66 2015 765 773
42. S.J. Head, S. Kaul, J.G. Tijssen, and et al. Subgroup analyses in trial reports comparing percutaneous coronary intervention with coronary artery bypass surgery JAMA 310 2013 2097 2098